Welcome to the Department of Health Care Services Welcome to Medi-Cal Welcome to the Department of Health Care Services

Medi-Cal Logo
Click to Sign Up for MCSS emails

Nusinersen, Bezlotoxumab and Ustekinumab are Medi-Cal Benefits

October 12, 2017

Effective for dates of service on or after July 1, 2017, the following HCPCS codes are Medi-Cal benefits:

HCPCS Code Description
C9489 injection, nusinersen, 0.1 mg
C9490 injection, bezlotoxumab, 10 mg
Q9989 ustekinumab, for intravenous injection, 1 mg

In addition, code Q9989 replaces terminated code C9487 (ustekinumab, for intravenous injection, 1 mg). Affected claims will be reprocessed via an Erroneous Payment Correction (EPC). No action is required of providers.